ロード中...
Rapamycin in aging and disease: maximizing efficacy while minimizing side effects
Experimental geroscience has identified rapamycin as a top candidate for promoting healthy aging and longevity in mammals. As multiple independent studies have successfully reproduced the lifespan and healthspan promoting effects of rapamycin, the focus has shifted to possible translational use. Whi...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5216691/ https://ncbi.nlm.nih.gov/pubmed/27384492 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10381 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|